|
1
|
Prockop DJ: Marrow stromal cells as stem
cells for nonhematopoietic tissues. Science. 276:71–74. 1997.
View Article : Google Scholar
|
|
2
|
Uccelli A, Moretta L and Pistoia V:
Mesenchymal stem cells in health and disease. Nat Rev Immunol.
8:726–736. 2008. View
Article : Google Scholar
|
|
3
|
Shi Y, Su J, Roberts AI, Shou P, Rabson AB
and Ren G: How mesenchymal stem cells interact with tissue immune
responses. Trends Immunol. 33:136–143. 2012. View Article : Google Scholar :
|
|
4
|
Le Blanc K, Rasmusson I, Sundberg B,
Götherström C, Hassan M, Uzunel M and Ringdén O: Treatment of
severe acute graft-versus-host disease with third party
haploidentical mesenchymal stem cells. Lancet. 363:1439–1441. 2004.
View Article : Google Scholar
|
|
5
|
Stemberger S, Jamnig A, Stefanova N,
Lepperdinger G, Reindl M and Wenning GK: Mesenchymal stem cells in
a transgenic mouse model of multiple system atrophy:
Immunomodulation and neuroprotection. PLoS One. 6:e198082011.
View Article : Google Scholar :
|
|
6
|
Ortiz LA, Dutreil M, Fattman C, Pandey AC,
Torres G, Go K and Phinney DG: Interleukin 1 receptor antagonist
mediates the antiinflammatory and antifibrotic effect of
mesenchymal stem cells during lung injury. Proc Natl Acad Sci USA.
104:pp. 11002–11007. 2007; View Article : Google Scholar :
|
|
7
|
Lee RH, Pulin AA, Seo MJ, Kota DJ,
Ylostalo J, Larson BL, Semprun-Prieto L, Delafontaine P and Prockop
DJ: Intravenous hMSCs improve myocardial infarction in mice because
cells embolized in lung are activated to secrete the
anti-inflammatory protein TSG-6. Cell Stem Cell. 5:54–63. 2009.
View Article : Google Scholar :
|
|
8
|
Tögel F, Hu Z, Weiss K, Isaac J, Lange C
and Westenfelder C: Administered mesenchymal stem cells protect
against ischemic acute renal failure through
differentiation-independent mechanisms. Am J Physiol Renal Physiol.
289:F31–F42. 2005. View Article : Google Scholar
|
|
9
|
Sheikh AM, Nagai A, Wakabayashi K,
Narantuya D, Kobayashi S, Yamaguchi S and Kim SU: Mesenchymal stem
cell transplantation modulates neuroinflammation in focal cerebral
ischemia: Contribution of fractalkine and IL-5. Neurobiol Dis.
41:717–724. 2011. View Article : Google Scholar
|
|
10
|
Lee JK, Jin HK, Endo S, Schuchman EH,
Carter JE and Bae JS: Intracerebral transplantation of bone
marrow-derived mesenchymal stem cells reduces amyloid-beta
deposition and rescues memory deficits in Alzheimer's disease mice
by modulation of immune responses. Stem Cells. 28:329–343.
2010.
|
|
11
|
Lda S Meirelles, Fontes AM, Covas DT and
Caplan AI: Mechanisms involved in the therapeutic properties of
mesenchymal stem cells. Cytokine Growth Factor Rev. 20:419–427.
2009. View Article : Google Scholar
|
|
12
|
Di Nicola M, Carlo-Stella C, Magni M,
Milanesi M, Longoni PD, Matteucci P, Grisanti S and Gianni AM:
Human bone marrow stromal cells suppress T-lymphocyte proliferation
induced by cellular or nonspecific mitogenic stimuli. Blood.
99:3838–3843. 2002. View Article : Google Scholar
|
|
13
|
Ooi YY, Ramasamy R, Rahmat Z, Subramaiam
H, Tan SW, Abdullah M, Israf DA and Vidyadaran S: Bone
marrow-derived mesenchymal stem cells modulate BV2 microglia
responses to lipopolysaccharide. Int Immunopharmacol. 10:1532–1540.
2010. View Article : Google Scholar
|
|
14
|
Németh K, Leelahavanichkul A, Yuen PS,
Mayer B, Parmelee A, Doi K, Robey PG, Leelahavanichkul K, Koller
BH, Brown JM, et al: Bone marrow stromal cells attenuate sepsis via
prostaglandin E(2)-dependent reprogramming of host macrophages to
increase their interleukin-10 production. Nat Med. 15:42–49. 2009.
View Article : Google Scholar
|
|
15
|
Aomatsu E, Takahashi N, Sawada S, Okubo N,
Hasegawa T, Taira M, Miura H, Ishisaki A and Chosa N: Novel
SCRG1/BST1 axis regulates self-renewal, migration, and osteogenic
differentiation potential in mesenchymal stem cells. Sci Rep.
4:36522014. View Article : Google Scholar :
|
|
16
|
Dandoy-Dron F, Guillo F, Benboudjema L,
Deslys JP, Lasmézas C, Dormont D, Tovey MG and Dron M: Gene
expression in scrapie. Cloning of a new scrapie-responsive gene and
the identification of increased levels of seven other mRNA
transcripts. J Biol Chem. 273:7691–7697. 1998. View Article : Google Scholar
|
|
17
|
Dron M, Bailly Y, Beringue V, Haeberlé AM,
Griffond B, Risold PY, Tovey MG, Laude H and Dandoy-Dron F: Scrg1
is induced in TSE and brain injuries and associated with autophagy.
Eur J Neurosci. 22:133–146. 2005. View Article : Google Scholar
|
|
18
|
Dron M, Bailly Y, Beringue V, Haeberlé AM,
Griffond B, Risold PY, Tovey MG, Laude H and Dandoy-Dron F: SCRG1,
a potential marker of autophagy in transmissible spongiform
encephalopathies. Autophagy. 2:58–60. 2006. View Article : Google Scholar
|
|
19
|
Dron M, Dandoy-Dron F, Guillo F,
Benboudjema L, Hauw JJ, Lebon P, Dormont D and Tovey MG:
Characterization of the human analogue of a Scrapie-responsive
gene. J Biol Chem. 273:18015–18018. 1998. View Article : Google Scholar
|
|
20
|
Dron M, Tartare X, Guillo F, Haik S,
Barbin G, Maury C, Tovey M and Dandoy-Dron F: Mouse scrapie
responsive gene 1 (Scrg1): Genomic organization, physical linkage
to sap30, genetic mapping on chromosome 8 and expression in
neuronal primary cell cultures. Genomics. 70:140–149. 2000.
View Article : Google Scholar
|
|
21
|
Aggarwal S and Pittenger MF: Human
mesenchymal stem cells modulate allogeneic immune cell responses.
Blood. 105:1815–1822. 2005. View Article : Google Scholar
|
|
22
|
Spaggiari GM, Capobianco A, Abdelrazik H,
Becchetti F, Mingari MC and Moretta L: Mesenchymal stem cells
inhibit natural killer-cell proliferation, cytotoxicity and
cytokine production: Role of indoleamine 2,3-dioxygenase and
prostaglandin E2. Blood. 111:1327–1333. 2008. View Article : Google Scholar
|
|
23
|
Sato K, Ozaki K, Oh I, Meguro A, Hatanaka
K, Nagai T, Muroi K and Ozawa K: Nitric oxide plays a critical role
in suppression of T-cell proliferation by mesenchymal stem cells.
Blood. 109:228–234. 2007. View Article : Google Scholar
|
|
24
|
Lee RH, Oh JY, Choi H and Bazhanov N:
Therapeutic factors secreted by mesenchymal stromal cells and
tissue repair. J Cell Biochem. 112:3073–3078. 2011. View Article : Google Scholar
|
|
25
|
Sawada S, Chosa N, Takizawa N, Yokota J,
Igarashi Y, Tomoda K, Kondo H, Yaegashi T and Ishisaki A:
Establishment of mesenchymal stem cell lines derived from the bone
marrow of green fluorescent protein-transgenic mice exhibiting a
diversity in intracellular transforming growth factor-β and bone
morphogenetic protein signaling. Mol Med Rep. 13:2023–2031.
2016.
|
|
26
|
Igarashi Y, Chosa N, Sawada S, Kondo H,
Yaegashi T and Ishisaki A: VEGF-C and TGF-β reciprocally regulate
mesenchymal stem cell commitment to differentiation into lymphatic
endothelial or osteoblastic phenotypes. Int J Mol Med.
37:1005–1013. 2016.
|
|
27
|
Godiska R, Chantry D, Raport CJ, Sozzani
S, Allavena P, Leviten D, Mantovani A and Gray PW: Human
macrophage-derived chemokine (MDC), a novel chemoattractant for
monocytes, monocyte-derived dendritic cells and natural killer
cells. J Exp Med. 185:1595–1604. 1997. View Article : Google Scholar :
|
|
28
|
Chang Ms, McNinch J, Elias C III, Manthey
CL, Grosshans D, Meng T, Boone T and Andrew DP: Molecular cloning
and functional characterization of a novel CC chemokine, stimulated
T cell chemotactic protein (STCP-1) that specifically acts on
activated T lymphocytes. J Biol Chem. 272:25229–25237. 1997.
View Article : Google Scholar
|
|
29
|
Schaniel C, Pardali E, Sallusto F,
Speletas M, Ruedl C, Shimizu T, Seidl T, Andersson J, Melchers F,
Rolink AG and Sideras P: Activated murine B lymphocytes and
dendritic cells produce a novel CC chemokine which acts selectively
on activated T cells. J Exp Med. 188:451–463. 1998. View Article : Google Scholar :
|
|
30
|
Mantovani A, Gray PA, Van Damme J and
Sozzani S: Macrophage-derived chemokine (MDC). J Leukoc Biol.
68:400–404. 2000.
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
32
|
Lavagno L, Ferrero E, Ortolan E, Malavasi
F and Funaro A: CD157 is part of a supramolecular complex with
CD11b/CD18 on the human neutrophil cell surface. J Biol Regul
Homeost Agents. 21:5–11. 2007.
|
|
33
|
Arthur JS and Ley SC: Mitogen-activated
protein kinases in innate immunity. Nat Rev Immunol. 13:679–692.
2013. View
Article : Google Scholar
|
|
34
|
Huang G, Shi LZ and Chi H: Regulation of
JNK and p38 MAPK in the immune system: Signal integration,
propagation and termination. Cytokine. 48:161–169. 2009. View Article : Google Scholar :
|
|
35
|
Ishihara K and Hirano T: BST-1/CD157
regulates the humoral immune responses in vivo. Chem Immunol.
75:235–255. 2000. View Article : Google Scholar
|
|
36
|
Malavasi F, Deaglio S, Funaro A, Ferrero
E, Horenstein AL, Ortolan E, Vaisitti T and Aydin S: Evolution and
function of the ADP ribosyl cyclase/CD38 gene family in physiology
and pathology. Physiol Rev. 88:841–886. 2008. View Article : Google Scholar
|
|
37
|
Kaisho T, Ishikawa J, Oritani K, Inazawa
J, Tomizawa H, Muraoka O, Ochi T and Hirano T: BST-1, a surface
molecule of bone marrow stromal cell lines that facilitates
pre-B-cell growth. Proc Natl Acad Sci USA. 91:pp. 5325–5329. 1994;
View Article : Google Scholar :
|
|
38
|
Goldstein SC and Todd RF III: Structural
and biosynthetic features of the Mo5 human myeloid differentiation
antigen. Tissue Antigens. 41:214–218. 1993. View Article : Google Scholar
|
|
39
|
Funaro A, Ortolan E, Bovino P, Lo Buono N,
Nacci G, Parrotta R, Ferrero E and Malavasi F: Ectoenzymes and
innate immunity: The role of human CD157 in leukocyte trafficking.
Front Biosci (Landmark Ed). 14:929–943. 2009. View Article : Google Scholar
|
|
40
|
Hussain AM, Lee HC and Chang CF:
Functional expression of secreted mouse BST-1 in yeast. Protein
Expr Purif. 12:133–137. 1998. View Article : Google Scholar
|
|
41
|
Okuyama Y, Ishihara K, Kimura N, Hirata Y,
Sato K, Itoh M, Ok LB and Hirano T: Human BST-1 expressed on
myeloid cells functions as a receptor molecule. Biochem Biophys Res
Commun. 228:838–845. 1996. View Article : Google Scholar
|
|
42
|
Lo Buono N, Parrotta R, Morone S, Bovino
P, Nacci G, Ortolan E, Horenstein AL, Inzhutova A, Ferrero E and
Funaro A: The CD157-integrin partnership controls transendothelial
migration and adhesion of human monocytes. J Biol Chem.
286:18681–18691. 2011. View Article : Google Scholar :
|
|
43
|
Funaro A, Ortolan E, Ferranti B, Gargiulo
L, Notaro R, Luzzatto L and Malavasi F: CD157 is an important
mediator of neutrophil adhesion and migration. Blood.
104:4269–4278. 2004. View Article : Google Scholar
|
|
44
|
Takeda K, Kaisho T and Akira S: Toll-like
receptors. Annu Rev Immunol. 21:335–376. 2003. View Article : Google Scholar
|
|
45
|
Poltorak A, He X, Smirnova I, Liu MY, Van
Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, et al:
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations
in Tlr4 gene. Science. 282:2085–2088. 1998. View Article : Google Scholar
|
|
46
|
Qureshi ST, Larivière L, Leveque G,
Clermont S, Moore KJ, Gros P and Malo D: Endotoxin-tolerant mice
have mutations in Toll-like receptor 4 (Tlr4). J Exp Med.
189:615–625. 1999. View Article : Google Scholar :
|
|
47
|
Wright SD: CD14 and innate recognition of
bacteria. J Immunol. 155:6–8. 1995.
|
|
48
|
Ulevitch RJ and Tobias PS:
Receptor-dependent mechanisms of cell stimulation by bacterial
endotoxin. Annu Rev Immunol. 13:437–457. 1995. View Article : Google Scholar
|
|
49
|
Shimazu R, Akashi S, Ogata H, Nagai Y,
Fukudome K, Miyake K and Kimoto M: MD-2, a molecule that confers
lipopolysaccharide responsiveness on toll-like receptor 4. J Exp
Med. 189:1777–1782. 1999. View Article : Google Scholar :
|
|
50
|
Akashi S, Shimazu R, Ogata H, Nagai Y,
Takeda K, Kimoto M and Miyake K: Cutting edge: Cell surface
expression and lipopolysaccharide signaling via the toll-like
receptor 4-MD-2 complex on mouse peritoneal macrophages. J Immunol.
164:3471–3475. 2000. View Article : Google Scholar
|
|
51
|
Viriyakosol S, Tobias PS, Kitchens RL and
Kirkland TN: MD-2 binds to bacterial lipopolysaccharide. J Biol
Chem. 276:38044–38051. 2001.
|
|
52
|
O'Neill LA, Dunne A, Edjeback M, Gray P,
Jefferies C and Wietek C: Mal and MyD88: Adapter proteins involved
in signal transduction by toll-like receptors. J Endotoxin Res.
9:55–59. 2003. View Article : Google Scholar
|
|
53
|
Kawai T, Adachi O, Ogawa T, Takeda K and
Akira S: Unresponsiveness of MyD88-deficient mice to endotoxin.
Immunity. 11:115–122. 1999. View Article : Google Scholar
|
|
54
|
Kawai T, Takeuchi O, Fujita T, Inoue J,
Mühlradt PF, Sato S, Hoshino K and Akira S: Lipopolysaccharide
stimulates the MyD88-independent pathway and results in activation
of IFN-regulatory factor 3 and the expression of a subset of
lipopolysaccharide-inducible genes. J Immunol. 167:5887–5894. 2001.
View Article : Google Scholar
|
|
55
|
West AP, Koblansky AA and Ghosh S:
Recognition and signaling by toll-like receptors. Annu Rev Cell Dev
Biol. 22:409–437. 2006. View Article : Google Scholar
|
|
56
|
Ghosh S and Karin M: Missing pieces in the
NF-kappaB puzzle. Cell. 109:S81–S96. 2002. View Article : Google Scholar
|
|
57
|
Gordon S and Martinez FO: Alternative
activation of macrophages: Mechanism and functions. Immunity.
32:593–604. 2010. View Article : Google Scholar
|
|
58
|
Nathan C: Points of control in
inflammation. Nature. 420:846–852. 2002. View Article : Google Scholar
|
|
59
|
Mantovani A, Sica A, Sozzani S, Allavena
P, Vecchi A and Locati M: The chemokine system in diverse forms of
macrophage activation and polarization. Trends Immunol. 25:677–686.
2004. View Article : Google Scholar
|
|
60
|
Nathan C and Ding A: Nonresolving
inflammation. Cell. 140:871–882. 2010. View Article : Google Scholar
|
|
61
|
Martinez FO, Gordon S, Locati M and
Mantovani A: Transcriptional profiling of the human
monocyte-to-macrophage differentiation and polarization: New
molecules and patterns of gene expression. J Immunol.
177:7303–7311. 2006. View Article : Google Scholar
|
|
62
|
Rao KM: MAP kinase activation in
macrophages. J Leukoc Biol. 69:3–10. 2001.
|
|
63
|
Rao KM, Meighan T and Bowman L: Role of
mitogen-activated protein kinase activation in the production of
inflammatory mediators: Differences between primary rat alveolar
macrophages and macrophage cell lines. J Toxicol Environ Health A.
65:757–768. 2002. View Article : Google Scholar
|
|
64
|
Bain J, Plater L, Elliott M, Shapiro N,
Hastie CJ, McLauchlan H, Klevernic I, Arthur JS, Alessi DR and
Cohen P: The selectivity of protein kinase inhibitors: A further
update. Biochem J. 408:297–315. 2007. View Article : Google Scholar :
|
|
65
|
Akhtar M, Watson JL, Nazli A and McKay DM:
Bacterial DNA evokes epithelial IL-8 production by a
MAPK-dependent, NF-kappaB-independent pathway. FASEB J.
17:1319–1321. 2003.
|
|
66
|
Fiebich BL, Schleicher S, Butcher RD,
Craig A and Lieb K: The neuropeptide substance P activates p38
mitogen-activated protein kinase resulting in IL-6 expression
independently from NF-kappa B. J Immunol. 165:5606–5611. 2000.
View Article : Google Scholar
|
|
67
|
Patel DN, King CA, Bailey SR, Holt JW,
Venkatachalam K, Agrawal A, Valente AJ and Chandrasekar B:
Interleukin-17 stimulates C-reactive protein expression in
hepatocytes and smooth muscle cells via p38 MAPK and
ERK1/2-dependent NF-kappaB and C/EBPbeta activation. J Biol Chem.
282:27229–27238. 2007. View Article : Google Scholar
|
|
68
|
Tokuda M, Miyamoto R, Sakuta T, Nagaoka S
and Torii M: Substance P activates p38 mitogen-activated protein
kinase to promote IL-6 induction in human dental pulp fibroblasts.
Connect Tissue Res. 46:153–158. 2005. View Article : Google Scholar
|
|
69
|
Zampetaki A, Mitsialis SA, Pfeilschifter J
and Kourembanas S: Hypoxia induces macrophage inflammatory
protein-2 (MIP-2) gene expression in murine macrophages via
NF-kappaB: The prominent role of p42/p44 and PI3 kinase pathways.
FASEB J. 18:1090–1092. 2004.
|
|
70
|
Yamashita U and Kuroda E: Regulation of
macrophage-derived chemokine (MDC, CCL22) production. Crit Rev
Immunol. 22:105–114. 2002. View Article : Google Scholar
|
|
71
|
Layseca-Espinosa E, Korniotis S, Montandon
R, Gras C, Bouillié M, Gonzalez-Amaro R, Dy M and Zavala F:
CCL22-producing CD8α- myeloid dendritic cells mediate regulatory T
cell recruitment in response to G-CSF treatment. J Immunol.
191:2266–2272. 2013. View Article : Google Scholar
|
|
72
|
Iellem A, Mariani M, Lang R, Recalde H,
Panina-Bordignon P, Sinigaglia F and D'Ambrosio D: Unique
chemotactic response profile and specific expression of chemokine
receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp
Med. 194:847–853. 2001. View Article : Google Scholar :
|
|
73
|
Curiel TJ, Coukos G, Zou L, Alvarez X,
Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L,
Burow M, et al: Specific recruitment of regulatory T cells in
ovarian carcinoma fosters immune privilege and predicts reduced
survival. Nat Med. 10:942–949. 2004. View
Article : Google Scholar
|
|
74
|
Li YQ, Liu FF, Zhang XM, Guo XJ, Ren MJ
and Fu L: Tumor secretion of CCL22 activates intratumoral treg
infiltration and is independent prognostic predictor of breast
cancer. PLoS One. 8:e763792013. View Article : Google Scholar :
|
|
75
|
Flytlie HA, Hvid M, Lindgreen E,
Kofod-Olsen E, Petersen EL, Jørgensen A, Deleuran M, Vestergaard C
and Deleuran B: Expression of MDC/CCL22 and its receptor CCR4 in
rheumatoid arthritis, psoriatic arthritis and osteoarthritis.
Cytokine. 49:24–29. 2010. View Article : Google Scholar
|
|
76
|
Yanai M, Sato K, Aoki N, Takiyama Y,
Oikawa K, Kobayashi H, Kimura S, Harabuchi Y and Tateno M: The role
of CCL22/macrophage-derived chemokine in allergic rhinitis. Clin
Immunol. 125:291–298. 2007. View Article : Google Scholar
|
|
77
|
Nakazato J, Kishida M, Kuroiwa R, Fujiwara
J, Shimoda M and Shinomiya N: Serum levels of Th2 chemokines,
CCL17, CCL22 and CCL27, were the important markers of severity in
infantile atopic dermatitis. Pediatr Allergy Immunol. 19:605–613.
2008.
|
|
78
|
Niens M, Visser L, Nolte IM, van der
Steege G, Diepstra A, Cordano P, Jarrett RF, Te Meerman GJ, Poppema
S and van den Berg A: Serum chemokine levels in hodgkin lymphoma
patients: Highly increased levels of CCL17 and CCL22. Br J
Haematol. 140:527–536. 2008. View Article : Google Scholar
|
|
79
|
Jafarzadeh A, Ebrahimi HA, Bagherzadeh S,
Zarkesh F, Iranmanesh F, Najafzadeh A, Khosravimashizi A, Nemati M,
Sabahi A, Hajghani H, et al: Lower serum levels of Th2-related
chemokine CCL22 in women patients with multiple sclerosis: A
comparison between patients and healthy women. Inflammation.
37:604–610. 2014. View Article : Google Scholar
|
|
80
|
Nagata S: Apoptosis and autoimmune
diseases. Ann N Y Acad Sci. 1209:10–16. 2010. View Article : Google Scholar
|
|
81
|
Szondy Z, Garabuczi E, Joós G, Tsay GJ and
Sarang Z: Impaired clearance of apoptotic cells in chronic
inflammatory diseases: Therapeutic implications. Front Immunol.
5:3542014. View Article : Google Scholar :
|
|
82
|
Furukawa S, Kuwajima Y, Chosa N, Satoh K,
Ohtsuka M and Miura H, Kimura M, Inoko H, Ishisaki A, Fujimura A
and Miura H: Establishment of immortalized mesenchymal stem cells
derived from the submandibular glands of td to mato transgenic
mice. Exp Ther Med. 10:1380–1386. 2015.
|
